Refine by
Locations
- Europe
- Albania
- Andorra
- Austria
- Belarus
- Belgium
- Bosnia & Herzegovina
- Bulgaria
- Croatia
- Cyprus
- Czech Republic
- Denmark
- Estonia
- Faroe Islands
- Finland
- France
- Germany
- Greece
- Hungary
- Iceland
- Ireland
- Italy
- Kosovo
- Latvia
- Liechtenstein
- Lithuania
- Luxembourg
- Macedonia
- Malta
- Moldova
- Monaco
- Montenegro
- Netherlands
- Northern Ireland
- Norway
- Poland
- Portugal
- Romania
- San Marino
- Serbia
- Slovakia
- Slovenia
- Spain
- Sweden
- Switzerland
- Turkey
- Ukraine
- United Kingdom
- Vatican City
Inflammatory Phase Equipment Supplied In Europe
6 equipment items found
Manufactured by:Kiadis Pharma NV based inAmsterdam, NETHERLANDS
Amlitelimab is designed to rebalance the immune system by blocking inappropriate activation and proliferation of ‘pro-inflammatory’ effector T cells and promoting expansion of ‘anti-inflammatory’ regulatory T cells, without broad suppression of the immune system. We believe this mechanism-of-action means Amlitelimab could be applicable to ...
Manufactured by:Histocell based inDerio, SPAIN
Reoxcare is an innovative last generation wound dressing with unique antioxidant properties, which promotes the natural healing process of the wound. Its patented design is the result of years of Histocell research in regenerative ...
Manufactured by:DiAgam based inGhislenghien, BELGIUM
C-reactive protein (CRP) is an α1-globulin predominantly synthesized by hepatocytes. It consists of five identical non-glycosylated polypeptide subunits, linked together non-covalently, forming a protein of about 115 kDa. It is composed of few or no carbohydrates. ...
Manufactured by:DiAgam based inGhislenghien, BELGIUM
C-reactive protein (CRP) is an α1-globulin predominantly synthesized by hepatocytes. It consists of five identical non-glycosylated polypeptide subunits, linked together non-covalently, forming a protein of about 115 kDa. It is composed of few or no carbohydrates. ...
by:Abivax based inParis, FRANCE
ABX464 is an oral, first-in-class, small molecule that has demonstrated safety and profound anti-inflammatory activity in the completed Phase 2a and Phase 2b induction studies as well as in long-term maintenance studies in patients with moderate-to-severe ulcerative colitis (UC). In addition to the clinical observations in UC patients, Abivax ...
by:Abivax based inParis, FRANCE
ABX464 is an oral, first-in-class, small molecule that has demonstrated safety and profound anti-inflammatory activity in the completed Phase 2a and Phase 2b induction studies as well as in ongoing long-term maintenance studies in patients with moderate-to-severe ulcerative colitis (UC).Due to the clinical similarities of Crohn’s disease ...